Albervis's rheumatoid arthritis drug Adam monoclonal antibody is the best -selling prescription medicine stake sports betting appstake online sports bettingin the world，But EU Supervisory Commissioner pointed out，The details of the clinical trials of the drug are still hidden for no reason。

Ada Mipida has been the focus of information on the open and transparent action of information，Although the European Pharmaceutical Bureau (EMA) is conducting plans to ask for public information，But Albervi has always kept confidential data。Two years ago，EMA agrees with the relevant data of the drug，Albervi filed a prosecution for this，Although the litigation is not held in the end，But EMA finally only announced some of these data。

 

  Many doctors and critics think，Free access data is crucial for medical decisions，It should allow independent experts to test drug information。June 10 European special agent o'Reilly Represents，This is not good enough，EMA still retains the details of clinical trial data based on the company's commercial interests。

 

  O ' Reilly point My stake betting appStake Sports Bettingout，Public health is more important than commercial interests，She believes the unfairness of the specific information is unfair。"I am asking EMA to consider the necessity of reserved these data，The agency should accept new requests to visit these reports，"She said in a statement，"Any valuable clinical information，Including a doctor、Patients and researchers，All must be disclosed to the interest public。"

 

  O 'Reilly's role is to investigate and deal with complaints about the management of EU institutions。EMA London Headquarters to O' Reilly did not find that the agency was happy with the poor management，and supplement the definition of disagreement with the definition of commercial secret data，Specific commercial interests will change over time。

 

  A spokesperson for Albervi said，The company is committed to being transparent with the attitude of "responsible"，But it also needs to protect business secret stake sports betting appMy stake betting appinformation。In recent years，Global Pharmaceutical Company is facing increasing pressure on clinical trial information.，These companies have also received many complaints，pointed out that they tried to conceal the disadvantaged information in the past。

EMA has taken the lead in promoting information disclosure，and promised to cancel the confidentiality of the test data submitted by the pharmaceutical company since 2010，This information is part of the company's application for new drugs。But this plan is difficult to continue because Albervi and Roche's Intermune proposed legal intervention。